These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 14755965

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F, Arikan C, Sertoz RY, Nart D, Aydogdu S, Yagci RV.
    Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection.
    Mutimer D, Dowling D, Cane P, Ratcliffe D, Tang H, O'Donnell K, Shaw J, Elias E, Pillay D.
    Antivir Ther; 2000 Dec; 5(4):273-7. PubMed ID: 11142622
    [Abstract] [Full Text] [Related]

  • 7. Treatment of chronic hepatitis B: interferon alfa first.
    Prescrire Int; 2001 Feb; 10(51):17-21. PubMed ID: 11503853
    [Abstract] [Full Text] [Related]

  • 8. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
    Acar A, Görenek L, Aydin A, Eyigün CP, Eken A, Sayal A, Pahsa A.
    Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
    [Abstract] [Full Text] [Related]

  • 9. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment.
    Liaw YF.
    Liver Int; 2009 Jan; 29 Suppl 1():100-7. PubMed ID: 19207972
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Chronic hepatitis B. Recent advances in diagnosis and treatment].
    Bernardi M, Biselli M, Gramenzi A.
    Recenti Prog Med; 2002 Jan; 93(7-8):397-402. PubMed ID: 12138683
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
    Mazur W, Król F, Cianciara J, Nazzal K, Gładysz A, Juszczyk J, Bolewska B, Adamek J, Czajka B, Swietek K, Kryczka W, Gonciarz Z.
    Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. What is the optimal therapy for chronic hepatitis B?
    Lyra AC, Di Bisceglie AM.
    Minerva Med; 2001 Dec; 92(6):431-4. PubMed ID: 11740431
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks.
    Korba BE, Cote P, Hornbuckle W, Schinazi R, Gangemi JD, Tennant BC, Gerin JL.
    Antivir Ther; 2000 Jun; 5(2):95-104. PubMed ID: 10971862
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.